School of Health Policy and Management, York University, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.
Int J Soc Determinants Health Health Serv. 2023 Oct;53(4):518-527. doi: 10.1177/27551938231165158. Epub 2023 Mar 20.
Although regulation of pharmaceutical promotion in Canada is covered under the Food & Drugs Act and Regulations, in practice it is regulated by two codes, one a code administered by the Pharmaceutical Advertising Advisory Board and a second one controlled by Innovative Medicines Canada, the lobby organization for the large majority of the Canadian and foreign-owned pharmaceutical companies operating in Canada. This study examines complaints about code violations between 2012 and 2021 and puts those complaints and their outcomes into the context of the stringency of the codes, their governance, monitoring, penalties for violations, and compliance by companies. It combines the findings from this analysis with international experience with industry-run codes and concludes that overall, the Canadian codes are ineffective in controlling promotion. Finally, it offers recommendations for how regulation can be improved and how doctors' reliance on information from pharmaceutical companies can be reduced.
虽然加拿大的药品促销监管涵盖在《食品和药品法》及其法规之下，但实际上，它由两个规范来管理，一个是由药品广告咨询委员会管理的规范，另一个是由加拿大创新药品协会（代表在加拿大运营的绝大多数加拿大和外资制药公司的游说组织）控制的规范。本研究调查了 2012 年至 2021 年期间对违反规范的投诉，并将这些投诉及其结果置于规范的严格性、治理、监测、违规处罚以及公司合规性的背景下。它将分析结果与国际上行业管理规范的经验相结合，并得出结论，总的来说，加拿大的规范在控制药品促销方面是无效的。最后，它提出了如何改进监管以及如何减少医生对制药公司信息的依赖的建议。
